Header Logo

Connection

MELINDA YATES to Cystadenocarcinoma, Serous

Back to Details
This is a "connection" page, showing publications MELINDA YATES has written about Cystadenocarcinoma, Serous.
MELINDA YATES
Connection Strength
0.124
Cystadenocarcinoma, Serous
  1. Lymphocyte-specific kinase expression is a prognostic indicator in ovarian cancer and correlates with a prominent B cell transcriptional signature. Cancer Immunol Immunother. 2019 Sep; 68(9):1515-1526.
    View in: PubMed
    Score: 0.124
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.